Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2016 Publisher: Omega Pharma Ltd., 1st Floor, 32 Vauxhall Bridge Road, LONDON, SW1V 2SA, United Kingdom
Fenistil Cold Sore Cream is indicated for the treatment of herpes simplex virus infections of the lips and face (herpes labialis) in adults (including older people) and children over 12 years of age.
Fenistil Cold Sore Cream is not recommended for use in immunocompromised patients; such patients should consult a physician concerning the treatment of any infection.
Fenistil Cold Sore Cream should be applied at approximately two hourly intervals during waking hours, (approximately 8 times a day). Treatment should be continued for 4 days. If the condition gets worse or does not improve after 4 days treatment, seek medical advice.
Treatment should be started as early as possible after the first sign of an infection.
The safety and efficacy of Fenistil Cold Sore Cream in children below 12 years of age have not been established.
No data are available.
No untoward effects would be expected even if the entire contents of a container of Fenistil Cold Sore Cream were ingested orally; penciclovir is poorly absorbed following oral administration. However, some irritation in the mouth could occur. No specific treatment is necessary if accidental oral ingestion occurs.
2g aluminium tubes – 3 years.
Store at temperatures not exceeding 30°C.
Do not freeze.
2g aluminium tube.
Any unused product or waste material should be disposed of in accordance with local requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
